Article
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Sept 2023
Segura Pedro Pérez, Quintela Noelia Vilariño, García María Martínez, Del Barco Berrón Sonia, Sarrió Regina Gironés, Gómez Jesús García, Castaño Almudena García, Martín Luis Miguel Navarro, Rubio Oscar Gallego, Losada Estela Pineda
Abstract excerpt
High-grade gliomas (HGG) are the most common primary brain malignancies and account for more than half of all malignant primary brain tumors. The new 2021 WHO classification divides adult HGG into four subtypes: grade 3 oligodendroglioma (1p/19 codeleted, IDH-mutant); grade 3 IDH-mutant astrocytoma; grade 4 IDH-mutant astrocytoma, and grade 4 IDH wild-type glioblastoma (GB). Radiotherapy (RT) and chemotherapy...
Topics
- Adult
- Humans
- Quality of Life
- Neoplasm Recurrence, Local
- Glioma
- Brain Neoplasms
- Glioblastoma
- Mutation